Sensus Healthcare - נכסים נקיים למניה בודדת SRTS

Stable component supplies and inventory reserves have driven capital growth, as confirmed by the BVPS value. This metric stands at 2.23. Success is based on physician recognition of non-invasive skin cancer treatment and insurance reimbursements. However, chip shortages and export restrictions in Asia are hindering the expansion of Sensus Healthcare (SRTS), creating certain challenges in system assembly.

Sensus Healthcare, Inc. (SRTS) maintains a patent-protected equipment base and FDA approvals that establish a robust foundation, minimizing asset impairment risks. The dynamics of the net book value per share reflect the difference between total assets and liabilities, allowing investors to assess the real value of their ownership stake and confirm business resilience through an analysis of this net book value per share.